Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

APO-DOXAZOSIN 1 MG

DOXAZOSIN (DOXAZOSIN MESYLATE) : 1 MG · DIN 02240588 · APOTEX INC

Health Canada status: MARKETED

What is APO-DOXAZOSIN?

APO-DOXAZOSIN 1 MG contains DOXAZOSIN (DOXAZOSIN MESYLATE) : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 02240588, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 22-Jul-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is APO-DOXAZOSIN used for?

APO-DOXAZOSIN (doxazosin mesylate) is indicated in the treatment of mild to moderate essential hypertension. It is employed in a general treatment program in association with a thiazide diuretic and/or other antihypertensive agents, as needed, for proper patient response. APO-DOXAZOSIN is also indicated for the treatment of symptoms of benign prostatic hyperplasia (BPH).

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02240588
Brand nameAPO-DOXAZOSIN
Generic / active ingredientDOXAZOSIN (DOXAZOSIN MESYLATE) : 1 MG
ManufacturerAPOTEX INC
Strength1 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeC02CA04 DOXAZOSIN
AHFS class24:20.00
BiosimilarNo
Health Canada statusMARKETED
Status date22-Jul-1999
Original market date1999-07-22 00:00:00

How is it stored and handled?

null

How is it supplied?

null

What can be used instead?

Other Canadian products sharing ATC code C02CA04 DOXAZOSIN. 9 of 28 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
APO-DOXAZOSIN2 MGTABLETAPOTEX INCMARKETEDDIN 02240589
APO-DOXAZOSIN4 MGTABLETAPOTEX INCMARKETEDDIN 02240590
JAMP-DOXAZOSIN1 MGTABLETJAMP PHARMA CORPORATIONMARKETEDDIN 02489937
JAMP-DOXAZOSIN2 MGTABLETJAMP PHARMA CORPORATIONMARKETEDDIN 02489945
JAMP-DOXAZOSIN4 MGTABLETJAMP PHARMA CORPORATIONMARKETEDDIN 02489953
TEVA-DOXAZOSIN1 MGTABLETTEVA CANADA LIMITEDMARKETEDDIN 02242728
TEVA-DOXAZOSIN2 MGTABLETTEVA CANADA LIMITEDMARKETEDDIN 02242729
TEVA-DOXAZOSIN4 MGTABLETTEVA CANADA LIMITEDMARKETEDDIN 02242730
CARDURA-1 TAB 1MG1 MGTABLETPFIZER CANADA ULCCANCELLED POST MARKETDIN 01958100
CARDURA-1,2,AND 44 MGKIT ; TABLETASTRAZENECA CANADA INCCANCELLED PRE MARKETDIN 02231762

Who else supplies DOXAZOSIN worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. DOXAZOSIN appears in 79 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for APO-DOXAZOSIN

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for APO-DOXAZOSIN

Health Canada Drug Product Database (DPD), DIN 02240588. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.